Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

While Trump has been wildly inconsistent on his plans for reciprocal tariffs, levies on imported pharmaceuticals appear to be ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

Peter R. Orszag, the C.E.O. of Lazard, discusses how markets are reacting to the uncertainty of Trump’s tariffs.

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might "go wild" on ...

Trump’s latest tariff vow threatens to disrupt supplies of obesity drugs such as Mounjaro and Wegovy as pharma giants face ...

When David Bergeron went to work at the office that would become the Department of Education nearly 50 years ago, higher-ups pointed him to a provision that barred staffers from getting involved ...

BUFFALO, N.Y. — President Trump brought up the subject of tariffs for the overseas pharmaceutical industry at a D.C. dinner for Republican members of Congress on Tuesday night.

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship ...

The U.S. does not buy drugs directly for a national health system, as countries such as England and Germany do, instead ...